Steiner, M.; Marsicano, G.; Nestler, E. J.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Endocannabinoid signaling modulates HPA axis activity in the mouse - implications for depression disorders. Pharmacopsychiatry 40 (5), p. 217 - 217 (2007)

Thoeringer, C. K.; Wultsch, T.; Shahbazian, A.; Painsipp, E.; Holzer, P.: Multidrug-resistance gene 1-type p-glycoprotein (MDR1 p-gp) inhibition by tariquidar impacts on neuroendocrine and behavioral processing of stress. Psychoneuroendocrinology 32 (8-10), pp. 1028 - 1040 (2007)

Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kohli, M.; Kloiber, S.; Salyakina, D.; Thoeringer, C. K.; Lieb, R.; Uhr, M. et al.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. Pharmacopsychiatry 40 (5), p. 217 - 217 (2007)

Wehrle, R.; Beitinger, P.; Dalal, M.; Schuld, A.; Wetter, T. C.; Pollmacher, T.: Daytime sleep after glucose intake in patients with narcolepsy. Pharmacopsychiatry 40 (5), p. 241 - 241 (2007)

Wochnik, G.; Schuelke, J.; Lang-Rollin, I.; Berning, B.; Rein, T.: Differential effects of TPR proteins on steroid receptor signaling. Pharmacopsychiatry 40 (5), p. 218 - 218 (2007)

Wöhr, M.; Dahlhoff, M.; Siegmund, A.; Wolf, E.; Holsboer, F.; Schwarting, R. K. W.; Wotjak, C. T.: Nature or nurture? Revealing the effects of genetic background, sex, and maternal care on isolation-induced ultrasonic calling in mice pups by using a uterine-transfer procedure. Behavioural Pharmacology 18 (Suppl. 1), pp. S72 - S73 (2007)

Wolferstätter, M.; Glasl, L.; Marwedel, A. L.; Bunck, M.; Landgraf, R.; Touma, C.: Linking cognitive abilities and stress reactivity: insights from the HR/IR/LR mouse model. Pharmacopsychiatry 40 (5), p. 218 - 218 (2007)

Wollweber, B. T.; Braun, H. A.; Voigt, K.: Effect of alcohol on hypothalamus neurons. Pharmacopsychiatry 40 (5), p. 237 - 237 (2007)

Zimmermann, P.; Brueckl, T.; Lieb, R.; Ising, M.; Wittchen, H. U.: The interplay of familial depression liability and adverse life events in predicting the first onset of depression during a ten-year follow-up. Pharmacopsychiatry 40 (5), p. 219 - 219 (2007)

Zschocke, J.; Allritz, C.; Engele, J.; Rein, T.: Epigenetic regulation of the human EAAT2 gene expression in glioma cells and normal brain. Pharmacopsychiatry 40 (5), p. 251 - 251 (2007)

Steiger, A.: Ghrelin and sleep-wake regulation. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 292, doi:10.1152/ajpregu.00618.2006., pp. R573 - R574 (2007)

Kloiber, S.; Ising, M.; Reppermund, S.; Horstmann, S.; Dose, T.; Majer, M.; Zihl, J.; Pfister, H.; Unschuld, P. G.; Holsboer, F. et al.; Lucae, S.: Overweight and obesity affect treatment response in major depression. Biological Psychiatry 62 (4), pp. 321 - 326 (2007)

Saarimaki-Vire, J.; Peltopuro, P.; Lahti, L.; Naserke, T.; Blak, A. A.; Vogt Weisenhorn, D. M.; Yu, K.; Ornitz, D. M.; Wurst, W.; Partanen, J.: Fibroblast growth factor receptors cooperate to regulate neural progenitor properties in the developing midbrain and hindbrain. Journal of Neuroscience 27 (32), pp. 8581 - 8592 (2007)

Beesdo, K.; Bittner, A.; Pine, D. S.; Stein, M. B.; Höfler, M.; Lieb, R.; Wittchen, H.-U.: Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Archives of General Psychiatry 64 (8), pp. 903 - 912 (2007)

Deussing, J. M.; Kuhne, C.; Pütz, B.; Panhuysen, M.; Breu, J.; Stenzel-Poore, M. P.; Holsboer, F.; Wurst, W.: Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity. Journal of Cerebral Blood Flow and Metabolism 27 (8), pp. 1476 - 1495 (2007)

Erhardt, A.; Lucae, S.; Unschuld, P. G.; Ising, M.; Kern, N.; Salyakina, D.; Lieb, R.; Uhr, M.; Binder, E. B.; Keck, M. E. et al.; Müller-Myhsok, B.; Holsboer, F.: Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. Journal of Affective Disorders 101 (1-3), pp. 159 - 168 (2007)

Fulda, S.; Wetter, T. C.: The influence of different definition criteria on the PLM index. Sleep Medicine 8 (5), pp. 484 - 490 (2007)

Garcia-Borreguero, D.; Allen, R. P.; Kohnen, R.; Högl, B.; Trenkwalder, C.; Oertel, W.; Hening, W. A.; Paulus, W.; Rye, D.; Walters, A. et al.; Winkelmann, J.: Diagnostic standards for dopaminergic augmentation of restless legs syndrome: Report from a World Association of Sleep Medicine - International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. Sleep Medicine 8 (5), pp. 520 - 530 (2007)

Kemlink, D.; Montagna, P.; Winkelmann, J.: Suggestive evidence for a new Restless Legs Syndrome (RLS) locus on chromosome 19. European Journal of Neurology 14 (Suppl. 1), p. 14 - 14 (2007)

Meyer, S.; Ipek, M.; Keth, A.; Minnemann, T.; Von Mach, M. A.; Weise, A.; Ittner, J. R.; Nawroth, P. P.; Plöckinger, U.; Stalla, G. K. et al.; Tuschy, U.; Weber, M. M.; Kann, P. H.: Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Growth Hormone & IGF Research 17 (4), pp. 307 - 314 (2007)